Mitochondrial Alterations near Amyloid Plaques in an Alzheimer's Disease Mouse Model
暂无分享,去创建一个
Brian J. Bacskai | Jing Xu | Alberto Serrano-Pozo | B. Bacskai | A. Serrano‐Pozo | Hong Xie | L. Borrelli | Hong Xie | JiSong Guan | Laura A. Borrelli | Jisong Guan | Jing Xu
[1] S. Remington,et al. Redox-sensitive green fluorescent protein: probes for dynamic intracellular redox responses. A review. , 2008, Methods in molecular biology.
[2] Jaime Grutzendler,et al. Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches , 2004, Nature Neuroscience.
[3] J. Blass,et al. Abnormalities of mitochondrial enzymes in Alzheimer disease , 1998, Journal of Neural Transmission.
[4] D. Chan. Mitochondria: Dynamic Organelles in Disease, Aging, and Development , 2006, Cell.
[5] Robert B. Petersen,et al. Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.
[6] M. Mattson,et al. Impairment of Glucose and Glutamate Transport and Induction of Mitochondrial Oxidative Stress and Dysfunction in Synaptosomes by Amyloid β‐Peptide: Role of the Lipid Peroxidation Product 4‐Hydroxynonenal , 1997, Journal of neurochemistry.
[7] H. Fukui,et al. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis? , 2008, Trends in Neurosciences.
[8] D. Holtzman,et al. Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease. , 2012, International journal of clinical and experimental pathology.
[9] Brian J. Bacskai,et al. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease , 2006, Neurobiology of Disease.
[10] M. Duchen,et al. β-Amyloid Peptides Induce Mitochondrial Dysfunction and Oxidative Stress in Astrocytes and Death of Neurons through Activation of NADPH Oxidase , 2004, The Journal of Neuroscience.
[11] M. Sekutowicz,et al. Rapid cell death is preceded by amyloid plaque-mediated oxidative stress , 2013, Proceedings of the National Academy of Sciences.
[12] W. Parker,et al. Cytochrome Oxidase Deficiency in Alzheimer's Disease a , 1991, Annals of the New York Academy of Sciences.
[13] Reham M. Abdel-Kader,et al. Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease , 2012, Molecular Neurobiology.
[14] Xi Chen,et al. Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .
[15] D. Davies,et al. Neurodegenerative Changes Associated with β-Amyloid Deposition in the Brains of Mice Carrying Mutant Amyloid Precursor Protein and Mutant Presenilin-1 Transgenes , 2001, Experimental Neurology.
[16] T. Crombleholme,et al. Optimized large-scale production of high titer lentivirus vector pseudotypes. , 2004, Journal of virological methods.
[17] M. Mattson,et al. Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. , 1998, Brain research.
[18] G. Schultz,et al. Positive effects of pollution? , 1996, Nature.
[19] M. Mattson,et al. Mitochondria in Neuroplasticity and Neurological Disorders , 2008, Neuron.
[20] S. Perry,et al. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. , 2011, BioTechniques.
[21] S. Lipton,et al. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function , 1995, Neuron.
[22] M. Beal,et al. Oxidative damage in Alzheimer's , 1996, Nature.
[23] R. Tsien,et al. Imaging Dynamic Redox Changes in Mammalian Cells with Green Fluorescent Protein Indicators* , 2004, Journal of Biological Chemistry.
[24] P. Reddy,et al. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. , 2011, Human molecular genetics.
[25] Xiongwei Zhu,et al. Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins , 2008, Proceedings of the National Academy of Sciences.
[26] Brian J. Bacskai,et al. Aβ Plaques Lead to Aberrant Regulation of Calcium Homeostasis In Vivo Resulting in Structural and Functional Disruption of Neuronal Networks , 2008, Neuron.
[27] M L Walsh,et al. Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy , 1981, The Journal of cell biology.
[28] P. Reddy,et al. Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer’s Disease , 2012, Pharmaceuticals.
[29] G. Perry,et al. Increased Autophagic Degradation of Mitochondria in Alzheimer Disease , 2007, Autophagy.
[30] D. Borchelt,et al. Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins , 1997, Neuron.
[31] D. Nicholls. Fluorescence measurement of mitochondrial membrane potential changes in cultured cells. , 2012, Methods in molecular biology.
[32] I. Ferrer,et al. Dystrophic neurites of senile plaques in Alzheimer’s disease are deficient in cytochrome c oxidase , 2008, Acta Neuropathologica.
[33] P. T. Nguyen,et al. Dendritic Spine Abnormalities in Amyloid Precursor Protein Transgenic Mice Demonstrated by Gene Transfer and Intravital Multiphoton Microscopy , 2005, The Journal of Neuroscience.
[34] L. Mosconi,et al. Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[35] H. Möller,et al. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients , 2000, Neurobiology of Aging.
[36] D. Holtzman,et al. Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease , 2008, Nature.
[37] P. Reddy,et al. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage. , 2011, Human molecular genetics.
[38] Kristina D. Micheva,et al. Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques , 2009, Proceedings of the National Academy of Sciences.
[39] Vishwanath T. Anekonda,et al. Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeutics. , 2012, Biochimica et biophysica acta.
[40] P. Cras,et al. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[41] M. Mattson,et al. Amyloid β-peptide induces apoptosis-related events in synapses and dendrites , 1998, Brain Research.
[42] J. Quinn,et al. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression. , 2006, Human molecular genetics.
[43] R. Petersen,et al. Mild cognitive impairment , 2006, The Lancet.
[44] George Perry,et al. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer’s disease , 2009, Journal of neurochemistry.
[45] M. Poot,et al. Efficacy of MitoTracker Green™ and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues , 2004, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[46] P. Reddy,et al. Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease , 2009, Experimental Neurology.
[47] G. Perkins,et al. Mitochondrial fragmentation in neurodegeneration , 2008, Nature Reviews Neuroscience.
[48] T. Smith,et al. J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. , 1991, Biochemistry.